MetLife Investment Management’s Corcept Therapeutics CORT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$429K	Sell	5,843 -41,520	-88%	-$3.05M	﹤0.01%	1755
2025 Q1	$5.41M	Sell	47,363 -1,481	-3%	-$169K	0.03%	569
2024 Q4	$2.46M	Buy	48,844 +2,186	+5%	+$110K	0.01%	938
2024 Q3	$2.16M	Sell	46,658 -180	-0.4%	-$8.33K	0.01%	977
2024 Q2	$1.52M	Buy	46,838 +4,515	+11%	+$147K	0.01%	1112
2024 Q1	$1.07M	Hold	42,323	–	–	0.01%	1260
2023 Q4	$1.37M	Hold	42,323	–	–	0.01%	1136
2023 Q3	$1.15M	Hold	42,323	–	–	0.01%	1161
2023 Q2	$942K	Sell	42,323 -4,776	-10%	-$106K	0.01%	1299
2023 Q1	$1.02M	Hold	47,099	–	–	0.01%	1216
2022 Q4	$957K	Hold	47,099	–	–	0.01%	1235
2022 Q3	$1.21M	Hold	47,099	–	–	0.01%	1097
2022 Q2	$1.12M	Hold	47,099	–	–	0.01%	1157
2022 Q1	$1.06M	Buy	47,099 +13,250	+39%	+$298K	0.01%	1290
2021 Q4	$670K	Hold	33,849	–	–	0.01%	1329
2021 Q3	$666K	Sell	33,849 -5,535	-14%	-$109K	0.01%	1364
2021 Q2	$866K	Hold	39,384	–	–	0.01%	1247
2021 Q1	$937K	Hold	39,384	–	–	0.01%	1185
2020 Q4	$1.03M	Sell	39,384 -4,062	-9%	-$106K	0.01%	1117
2020 Q3	$756K	Hold	43,446	–	–	0.01%	1169
2020 Q2	$731K	Hold	43,446	–	–	0.01%	1176
2020 Q1	$517K	Hold	43,446	–	–	0.01%	1201
2019 Q4	$526K	Hold	43,446	–	–	0.01%	1441
2019 Q3	$614K	Hold	43,446	–	–	0.01%	1310
2019 Q2	$484K	Hold	43,446	–	–	0.01%	1496
2019 Q1	$510K	Hold	43,446	–	–	0.01%	1442
2018 Q4	$580K	Hold	43,446	–	–	0.01%	1279
2018 Q3	$609K	Hold	43,446	–	–	0.01%	1409
2018 Q2	$683K	Hold	43,446	–	–	0.01%	1214
2018 Q1	$715K	Hold	43,446	–	–	0.01%	1162
2017 Q4	$785K	Buy	+43,446	New	+$785K	0.01%	1140